<?xml version="1.0" encoding="UTF-8"?>
<fig id="Fig5">
 <label>Fig. 5</label>
 <caption>
  <p>Effects of olaparib on influenza virus challenge-induced PARylated protein content and p65, IκBα phosphorylation in lung tissues at day 6 post-infection (
   <italic>n</italic> = 8 for each group). Western blot analysis of PARylated protein content (a) and p-p65, p65, p- IκBα, and IκBα (b) in lung samples from each experimental group. The relative expressions were normalized to control (c, d, e). Data are presented as mean ± SD. 
   <sup>##</sup>
   <italic>p</italic> &lt; 0.01 and 
   <sup>###</sup>
   <italic>p</italic> &lt; 0.001 compared with the control. 
   <sup>**</sup>
   <italic>p</italic> &lt; 0.01 and 
   <sup>***</sup>
   <italic>p</italic> &lt; 0.001 compared with IAV
  </p>
 </caption>
 <graphic xlink:href="10096_2020_4020_Fig5_HTML" id="MO5" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
